Artificial Differences in Clostridium difficile Infection Rates Associated with Disparity in Testing.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read Online Read More Add to Saved list
  • Additional Information
    • Subject Terms:
      CLOSTRIDIOIDES difficile; CLOSTRIDIUM diseases; CANCER hospitals; PUBLIC health surveillance; EPIDEMIOLOGY; BACTERIOLOGY technique; HOSPITAL care; HOSPITALS; HEALTH equity; NUCLEIC acid amplification techniques; DIAGNOSIS
    • Abstract:
      In 2015, Clostridium difficile testing rates among 30 US community, multispecialty, and cancer hospitals were 14.0, 16.3, and 33.9/1,000 patient-days, respectively. Pooled hospital onset rates were 0.56, 0.84, and 1.57/1,000 patient-days, respectively. Higher testing rates may artificially inflate reported rates of C. difficile infection. C. difficile surveillance should consider testing frequency. [ABSTRACT FROM AUTHOR]
    • Abstract:
      Copyright of Emerging Infectious Diseases is the property of Centers for Disease Control & Prevention (CDC) and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)